Entity coverage
NextCure, Inc.
NXTC · 6 events mapped
Market Ontology has mapped 6 distinct macro, policy, and market events to NXTC. Each entry below traces the causal channel from the driver to the assumption it moved.
Recent event impacts
Full ledger →- 2026-07-17EventMerger financing and potential dilution. The private placement is in connection with the merger, suggesting it's a key component of the combined entity's capitalization strategy.
- 2026-07-17EventStrategic acquisition of pipeline assets, potential for synergies, dilution from all-stock merger and concurrent private placement, integration risks.
- 2026-07-17EventRegulatory filing indicating an impending business combination. The specific terms and counterparty are unknown, leading to uncertainty.
- 2026-07-17EventDirect M&A announcement, potential for acquisition premium or deal uncertainty.
- 2026-07-14EventAcquisition of Avere Therapeutics, Inc. via an all-stock transaction. NextCure shareholders will own a portion of the combined entity. The combined company will focus on Avere's pipeline.
- 2026-06-25EventThe approval of an amended omnibus incentive plan suggests potential changes in executive and employee compensation structures, which could impact share-based compensation expenses and potentially share dilution over time. The 'watch' direction is due to the lack of specific details on the amendment
Continuous coverage for NXTC with alerts, structural playbooks, and options routing lives in the platform. Start a trial →